NEMERA · 4 hours ago
Lean & Continuous Improvement Intern
Nemera is a leading global manufacturer of complex drug delivery systems for the pharmaceutical industry. They are seeking a Lean & Continuous Improvement Intern to conduct time studies, provide project support, and assist with NPS support activities while gaining mentorship from the team.
BiotechnologyHealth CareManufacturingMedical Device
Responsibilities
Conducting Time studies
Providing project support to the team
Assisting with NPS (Net Promoter Score – Nemera production system) support activities
Qualification
Required
Student working towards a bachelor's degree in Engineering and preferably focused on industrial engineering or other related Engineering field
Candidates preferred to have completed their second year of engineering studies and entering Junior or Senior year
High problem-solving skills and self-direction
Ability to work in a team or individual contributor
Technical skills including problem-solving abilities and communication skills
Specific software proficiency (e.g., Excel)
Familiarity with Time studies
Knowledge of 5S principles
Understanding of Lean concepts such as Kanban and SMED (a plus)
Preferred
Familiarity with manufacturing and/or plastic injection molding
Technical skills including problem-solving abilities and communication skills
Specific software proficiency (e.g., Excel)
Familiarity with Time studies
Knowledge of 5S principles
Understanding of Lean concepts such as Kanban and SMED (a plus)
Company
NEMERA
Nemera is one of the world leaders in the design, development and manufacturing of high quality innovative drug delivery solutions.
H1B Sponsorship
NEMERA has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2024 (2)
2023 (1)
2022 (1)
2021 (3)
Funding
Current Stage
Late StageTotal Funding
unknown2018-10-17Acquired
Recent News
Company data provided by crunchbase